Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica Mendoza hosts.
Further Listening:
Trillion Dollar Shot
Why WeightWatche ... Show More
Apr 30
How IKEA Is Keeping Its Furniture Affordable
Tariffs, inflation and an energy crisis have driven up the cost of nearly every consumer good. Despite those economic headwinds, IKEA has tried to keep its furniture affordable. Juvencio Maeztu is the CEO of the Ingka Group, IKEA’s largest franchise, and he explains how the compa ... Show More
22m 48s
Apr 29
Move Over, Humans. China's Robots Are Taking Over
In China, humanoid robots are on the rise. Robots with heads and torsos have been spotted staffing the front desk at hotels, working factory floors, and serving lattes. It's all thanks to an investment boom and subsidies from the Chinese government, which is betting on "embodied ... Show More
20 m
Jul 2025
Why are Consumer Co CEOs Losing Their Jobs?
It’s been a turbulent fortnight for corporate leadership, with sudden CEO exits at companies like HUL, Coca Cola bottler HCCB, L’Oréal, Diageo, Kenvue and WPP. In this episode of The Morning Brief, host Ratna Bhushan speaks to ET’s Associate Editor Arijit Barman and Vibhav Dhawan ... Show More
26m 53s
Apr 2025
SOTS 2nd Hour: Tariff Updates, Earnings Wrap-up, and Is This Rally Real? – plus: Coca-Cola CEO Talks Results 4/29/25
<p>Fresh news on the tariff front when it comes to potential deals – and hopes of relief for the automakers… Carl Quintanilla, Sara Eisen, and David Faber broke down the latest from the White House, alongside the morning’s biggest earnings stories: from GM pulling guidance and de ... Show More
42m 32s